Author/Editor		Štalc, M; Tomšič, M; Ježovnik, MK; Poredoš, P
Title		Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome
Type		članek
Source		Clin Exp Rheumatol
Vol. and No.		Letnik 29, št. 4
Publication year		2011
Volume		str. 616-23
Language		eng
Abstract		Objectives: The study evaluated the systemic inflammatory response and endothelium-dependent and independent function of the brachial artery (BA) in systemic lupus erythematosus (SLE) patients with and without antiphospholipid syndrome (APS). Methods: The study group consisted of 42 women with SLE (21 without APS; mean age 36.1+/-9.1, and 21 with APS; mean age 43.9+/-13.1) and 22 healthy controls (mean age 43.5+/-10.3). Endothelium-dependent functional response was evacuate using the flow-mediated vasodilatation (FMD) of brachial artery and endothelium-independent vasodilatation by application of glyceryl trinitrate (GTN). Using biochemical methods, circulating inflammatory markers were determined. Results: In comparison to controls, in both groups of patients endothelium-dependent dilation of BA was significantly reduced, and there were no differences in FMD between patients with or without APS: SLE - 7.7% (11.9-12.1), SLE+APS 7.8% (2.4-12.8), controls - 14.6% (11.2-21.1), p<0.001. However, endothelium-independent dilation of the brachial artery was significantly lower in SLE-APS patients than in controls and also lower than in the SLE group: SLE - 24.3% (15.0-28.6), SLE+APS-17.4% (13.1-22.6), controls - 23.0% (17.8-30.1), p=0.015 vs. p=0.027. Patients with SLE had significantly higher values of VCAM-1, hs-CRP, and fibrinogen than controls. In patients with SLE+APS, an additional significant increase of inflammatory markers was registered. Conclusion: The results of our study indicate that patients with SLE have deteriorated endothelium-dependent and those with APS also independent vascular function which could be, together with increased inflammatory response, involved in vascular complications in these patients. The presence of APS aggravates systemic inflammatory response.
Descriptors		LUPUS ERYTHEMATOSUS, SYSTEMIC ANTIPHOSPHOLIPID SYNDROME BRACHIAL ARTERY ENDOTHELIUM, VASCULAR NITROGLYCERIN VASODILATION INFLAMMATION MEDIATORS FIBRINOGEN VASCULAR CELL ADHESION MOLECULE-1 C-REACTIVE PROTEIN